抗血小板药物治疗腔隙性梗死效果的Meta分析
目的评价抗血小板药物对腔隙性梗死患者二级预防的治疗效果。方法以stroke,lacunar infarction,platelet aggregation inhibitors,antiplatelet,randomized controlled trial等英文词汇计算机检索1980年1月1日-2016年11月20日美国国立医学图书馆生物医学信息检索系统、荷兰医学文摘、Cochrane在线图书馆等数据库收录的关于腔隙性梗死患者抗血小板治疗的随机对照临床试验,采用Jadad量表、Cochrane系统评价手册和Rev Man 5.3统计软件进行文献质量评价和Meta分析,R软件Gemtc程序包和...
Saved in:
| Published in | 中国现代神经疾病杂志 Vol. 17; no. 3; pp. 176 - 184 |
|---|---|
| Main Author | |
| Format | Journal Article |
| Language | Chinese |
| Published |
四川大学华西医院神经内科,成都,610041
2017
|
| Subjects | |
| Online Access | Get full text |
| ISSN | 1672-6731 |
| DOI | 10.3969/j.issn.1672-6731.2017.03.004 |
Cover
| Abstract | 目的评价抗血小板药物对腔隙性梗死患者二级预防的治疗效果。方法以stroke,lacunar infarction,platelet aggregation inhibitors,antiplatelet,randomized controlled trial等英文词汇计算机检索1980年1月1日-2016年11月20日美国国立医学图书馆生物医学信息检索系统、荷兰医学文摘、Cochrane在线图书馆等数据库收录的关于腔隙性梗死患者抗血小板治疗的随机对照临床试验,采用Jadad量表、Cochrane系统评价手册和Rev Man 5.3统计软件进行文献质量评价和Meta分析,R软件Gemtc程序包和JAGS软件进行网状Meta分析。结果共获得4068篇英文文献,经剔除重复和不符合纳入标准者,最终纳入12项质量较高（Jadad评分≥4分）的临床试验共24 969例腔隙性梗死患者。Meta分析显示：与安慰剂相比,抗血小板药物单抗治疗可以显著降低缺血性卒中复发率（RR=0.480,95%CI：0.300~0.780;P=0.003）和所有脑卒中复发率（RR=0.780,95%CI：0.630~0.970;P=0.030）;而抗血小板药物单抗与双抗治疗效果差异无统计学意义（缺血性卒中复发率：RR=0.900,95%CI：0.760~1.050,P=0.170;所有脑卒中复发率：RR=0.910,95%CI：0.820~1.010,P=0.070）。网状Meta分析（包括阿司匹林、安慰剂、西洛他唑和噻氯匹定4种干预措施）显示：仅西洛他唑治疗后所有脑卒中复发率低于阿司匹林（OR=0.341,95%Cr I：0.011~0.673）和安慰剂（OR=0.615,95%Cr I：0.191~1.042）。结论抗血小板药物单抗治疗可以显著降低腔隙性梗死患者缺血性卒中和所有脑卒中复发风险,且与双抗治疗效果无明显差异;西洛他唑较阿司匹林能够更显著降低腔隙性梗死患者所有脑卒中复发风险。 |
|---|---|
| AbstractList | 目的评价抗血小板药物对腔隙性梗死患者二级预防的治疗效果。方法以stroke,lacunar infarction,platelet aggregation inhibitors,antiplatelet,randomized controlled trial等英文词汇计算机检索1980年1月1日-2016年11月20日美国国立医学图书馆生物医学信息检索系统、荷兰医学文摘、Cochrane在线图书馆等数据库收录的关于腔隙性梗死患者抗血小板治疗的随机对照临床试验,采用Jadad量表、Cochrane系统评价手册和Rev Man 5.3统计软件进行文献质量评价和Meta分析,R软件Gemtc程序包和JAGS软件进行网状Meta分析。结果共获得4068篇英文文献,经剔除重复和不符合纳入标准者,最终纳入12项质量较高（Jadad评分≥4分）的临床试验共24 969例腔隙性梗死患者。Meta分析显示：与安慰剂相比,抗血小板药物单抗治疗可以显著降低缺血性卒中复发率（RR=0.480,95%CI：0.300~0.780;P=0.003）和所有脑卒中复发率（RR=0.780,95%CI：0.630~0.970;P=0.030）;而抗血小板药物单抗与双抗治疗效果差异无统计学意义（缺血性卒中复发率：RR=0.900,95%CI：0.760~1.050,P=0.170;所有脑卒中复发率：RR=0.910,95%CI：0.820~1.010,P=0.070）。网状Meta分析（包括阿司匹林、安慰剂、西洛他唑和噻氯匹定4种干预措施）显示：仅西洛他唑治疗后所有脑卒中复发率低于阿司匹林（OR=0.341,95%Cr I：0.011~0.673）和安慰剂（OR=0.615,95%Cr I：0.191~1.042）。结论抗血小板药物单抗治疗可以显著降低腔隙性梗死患者缺血性卒中和所有脑卒中复发风险,且与双抗治疗效果无明显差异;西洛他唑较阿司匹林能够更显著降低腔隙性梗死患者所有脑卒中复发风险。 目的 评价抗血小板药物对腔隙性梗死患者二级预防的治疗效果.方法 以stroke,lacunar infarction,platelet aggregation inhibitors,antiplatelet,randomized controlled trial等英文词汇计算机检索1980年1月1日-2016年11月20日美国国立医学图书馆生物医学信息检索系统、荷兰医学文摘、Cochrane在线图书馆等数据库收录的关于腔隙性梗死患者抗血小板治疗的随机对照临床试验,采用Jadad量表、Cochrane系统评价手册和RevMan 5.3统计软件进行文献质量评价和Meta分析,R软件Gemtc程序包和JAGS软件进行网状Meta分析.结果 共获得4068篇英文文献,经剔除重复和不符合纳入标准者,最终纳入12项质量较高(Jadad评分≥4分)的临床试验共24 969例腔隙性梗死患者.Meta分析显示:与安慰剂相比,抗血小板药物单抗治疗可以显著降低缺血性卒中复发率(RR=0.480,95％CI:0.300～0.780;P=0.003)和所有脑卒中复发率(RR=0.780,95％CI:0.630 ～ 0.970;P=0.030);而抗血小板药物单抗与双抗治疗效果差异无统计学意义(缺血性卒中复发率:RR=0.900,95％CI:0.760～ 1.050,P=0.170;所有脑卒中复发率:RR=0.910,95％CI:0.820～ 1.010,P=0.070).网状Meta分析(包括阿司匹林、安慰剂、西洛他唑和噻氯匹定4种干预措施)显示:仅西洛他唑治疗后所有脑卒中复发率低于阿司匹林(OR=0.341,95％CrI:0.011 ～ 0.673)和安慰剂(OR=0.615,95％CrI:0.191 ～ 1.042).结论 抗血小板药物单抗治疗可以显著降低腔隙性梗死患者缺血性卒中和所有脑卒中复发风险,且与双抗治疗效果无明显差异;西洛他唑较阿司匹林能够更显著降低腔隙性梗死患者所有脑卒中复发风险. |
| Abstract_FL | Objective To evaluate the efficacy of antiplatelet agents in secondary prevention of patients with lacunar infarct (LACI).Methods Retrieve relevant randomized controlled trials (RCTs) that reported antiplatelet therapy in patients with LACI from online databases (January 1,1980-November 20,2016) in PubMed,EMBASE/SCOPUS and Cochrane Online Library with key words:stroke,lacunar infarction,platelet aggregation inhibitors,antiplatelet,randomized controlled trial.Quality of studies was evaluated by using Jadad Scale and Cochrane Handbook for Systematic Reviews of Interventions.All data were pooled by RevMan 5.3 software for Meta-analysis.A network Meta-analysis was done by R software Gemtc and JAGS software.Results A total of 4068 articles were enrolled and 12 high-quality RCTs (Jadad ≥ 4 scores) with 24 969 eligible participants were finally included after excluding duplicates and those not meeting the inclusion criteria.Meta-analysis showed single antiplatelet therapy was more effective than placebo in reducing ischemic stroke recurrence rate (RR =0.480,95％CI:0.300-0.780;P =0.003) and any stroke recurrence rate (RR =0.780,95％CI:0.630-0.970;P =0.030).The efficacy of single antiplatelet therapy was not significantly different from that of dual antiplatelet therapy (ischemic stroke recurrence rate:RR =0.900,95％CI:0.760-1.050,P =0.170;any stroke recurrence rate:RR =0.910,95％CI:0.820-1.010,P =0.070).Network Meta-analysis (four interventions including aspirin,placebo,cilostazol and ticlopidine)showed that cilostazol was associated with a significant reduction in recurrence of any stroke compared with aspirin (OR =0.341,95％ CrI:0.011-0.673) and placebo (OR =0.615,95％ CrI:0.191-1.042).Conclusions Single antiplatelet therapy could significantly reduce the recurrence of any stroke,especially ischemic stroke in patients with LACI.There is no evidence showing that dual antiplatelet therapy is probably better than single therapy.Cilostazol is better than aspirin in reducing any stroke recurrence in the treatment of LACI. |
| Author | 徐达 陈邓 朱丽娜 谭戈 王海姣 刘凌 |
| AuthorAffiliation | 四川大学华西医院神经内科,成都610041 |
| AuthorAffiliation_xml | – name: 四川大学华西医院神经内科,成都,610041 |
| Author_FL | WANG Hai-jiao TAN Ge CHEN Deng ZHU Li-na LIU Ling XU Da |
| Author_FL_xml | – sequence: 1 fullname: XU Da – sequence: 2 fullname: CHEN Deng – sequence: 3 fullname: ZHU Li-na – sequence: 4 fullname: TAN Ge – sequence: 5 fullname: WANG Hai-jiao – sequence: 6 fullname: LIU Ling |
| Author_xml | – sequence: 1 fullname: 徐达 陈邓 朱丽娜 谭戈 王海姣 刘凌 |
| BookMark | eNo9j79Lw0AcxW-oYK39J8TFIfF7-cZczk2Kv6Di0r1cLklN0Ks2itqpg0oVRAc1WLSgiziI4trBv6aX-l8YqTg8Hjw-vMebIgXVVAEhsxRM5A6fj80oSZRJHWYZDkNqWkCZCWgC2AVS_M8nSTlJYgCgFMFyoEgW9UU6euoMP67049fo8j07f9Wfg-wuHZ3efPfudedFP6f6baBvu7r_kPVONoJ9Meye6f71NJkIxXYSlP-8RGory7XKmlHdXF2vLFUN6VDbCCxYCDh6HuRCKX0I3YBR3wol2BwF95BJyJ1TW4S29CRzOTLBGArknoslMjeuPRQqFKpRj5sHLZUP1o_8JI69dvv3LGB-NWdnxqzcaqrGXpTTu61oR7SO6w6jLkUXEX8Ak3hsGg |
| ContentType | Journal Article |
| Copyright | Copyright © Wanfang Data Co. Ltd. All Rights Reserved. |
| Copyright_xml | – notice: Copyright © Wanfang Data Co. Ltd. All Rights Reserved. |
| DBID | 2RA 92L CQIGP W91 ~WA 2B. 4A8 92I 93N PSX TCJ |
| DOI | 10.3969/j.issn.1672-6731.2017.03.004 |
| DatabaseName | 维普期刊资源整合服务平台 中文科技期刊数据库-CALIS站点 维普中文期刊数据库 中文科技期刊数据库-医药卫生 中文科技期刊数据库- 镜像站点 Wanfang Data Journals - Hong Kong WANFANG Data Centre Wanfang Data Journals 万方数据期刊 - 香港版 China Online Journals (COJ) China Online Journals (COJ) |
| DatabaseTitleList | |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| DocumentTitleAlternate | Efficacy of antiplatelet therapy for treating lacunar infarct：Meta-analysis |
| DocumentTitle_FL | Efficacy of antiplatelet therapy for treating lacunar infarct: Meta-analysis |
| EndPage | 184 |
| ExternalDocumentID | xdsjjbzz201703004 671813833 |
| GroupedDBID | --- -05 04C 2B. 2C~ 2RA 3V. 5VS 92F 92I 92L ABUWG ACGFS AFKRA ALMA_UNASSIGNED_HOLDINGS BENPR BPHCQ BVBZV CCEZO CCPQU CIEJG CQIGP CW9 EBD EIHBH EOJEC GROUPED_DOAJ IPNFZ KQ8 OBODZ OK1 PQQKQ PROAC RIG RNS TCJ TGQ U1G U5O W91 ~WA 4A8 93N ABJNI PSX |
| ID | FETCH-LOGICAL-c614-e205e93bb03bb3ccd0f8e71d2fc0493a9b37c03a9914af4cbc78937a773a39b83 |
| ISSN | 1672-6731 |
| IngestDate | Thu May 29 04:06:29 EDT 2025 Wed Feb 14 10:02:07 EST 2024 |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 3 |
| Keywords | Platelet aggregation inhibitors Meta分析 脑梗死 血小板聚集抑制剂 Brain infarction Meta-analysis |
| Language | Chinese |
| LinkModel | OpenURL |
| MergedId | FETCHMERGED-LOGICAL-c614-e205e93bb03bb3ccd0f8e71d2fc0493a9b37c03a9914af4cbc78937a773a39b83 |
| Notes | Objective To evaluate the efficacy of antiplatelet agents in secondary prevention ofpatients with lacunar infarct（LACI）. Methods Retrieve relevant randomized controlled trials（RCTs） thatreported antiplatelet therapy in patients with LACI from online databases（January 1,1980-November 20,2016） in Pub Med,EMBASE/SCOPUS and Cochrane Online Library with key words：stroke,lacunarinfarction,platelet aggregation inhibitors,antiplatelet,randomized controlled trial. Quality of studies wasevaluated by using Jadad Scale and Cochrane Handbook for Systematic Reviews of Interventions. All datawere pooled by Rev Man 5.3 software for Meta-analysis. A network Meta-analysis was done by R softwareGemtc and JAGS software. Results A total of 4068 articles were enrolled and 12 high-quality RCTs（Jadad ≥ 4 scores） with 24 969 eligible participants were finally included after excluding duplicates andthose not meeting the inclusion criteria. Meta-analysis showed single antiplatelet therapy was more effectivethan placebo in reducing isch |
| PageCount | 9 |
| ParticipantIDs | wanfang_journals_xdsjjbzz201703004 chongqing_primary_671813833 |
| PublicationCentury | 2000 |
| PublicationDate | 2017 |
| PublicationDateYYYYMMDD | 2017-01-01 |
| PublicationDate_xml | – year: 2017 text: 2017 |
| PublicationDecade | 2010 |
| PublicationTitle | 中国现代神经疾病杂志 |
| PublicationTitleAlternate | Chinese Journal of Contemporary Neurology and Neurosurgery |
| PublicationTitle_FL | Chinese Journal of Contemporary Neurology and Neurosurgery |
| PublicationYear | 2017 |
| Publisher | 四川大学华西医院神经内科,成都,610041 |
| Publisher_xml | – name: 四川大学华西医院神经内科,成都,610041 |
| SSID | ssj0001130260 ssib017477097 ssib038074726 ssib051368963 ssib001103733 |
| Score | 2.1081579 |
| Snippet | 目的评价抗血小板药物对腔隙性梗死患者二级预防的治疗效果。方法以stroke,lacunar infarction,platelet aggregation inhibitors,antiplatelet,randomized controlled trial... 目的 评价抗血小板药物对腔隙性梗死患者二级预防的治疗效果.方法 以stroke,lacunar infarction,platelet aggregation inhibitors,antiplatelet,randomized controlled... |
| SourceID | wanfang chongqing |
| SourceType | Aggregation Database Publisher |
| StartPage | 176 |
| SubjectTerms | Meta分析 脑梗死 血小板聚集抑制剂 |
| Title | 抗血小板药物治疗腔隙性梗死效果的Meta分析 |
| URI | http://lib.cqvip.com/qk/84230A/201703/671813833.html https://d.wanfangdata.com.cn/periodical/xdsjjbzz201703004 |
| Volume | 17 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVAFT databaseName: Open Access Digital Library issn: 1672-6731 databaseCode: KQ8 dateStart: 20100101 customDbUrl: isFulltext: true dateEnd: 99991231 titleUrlDefault: http://grweb.coalliance.org/oadl/oadl.html omitProxy: true ssIdentifier: ssj0001130260 providerName: Colorado Alliance of Research Libraries – providerCode: PRVAON databaseName: DOAJ Open Access Full Text issn: 1672-6731 databaseCode: DOA dateStart: 20100101 customDbUrl: isFulltext: true dateEnd: 99991231 titleUrlDefault: https://www.doaj.org/ omitProxy: true ssIdentifier: ssj0001130260 providerName: Directory of Open Access Journals – providerCode: PRVPQU databaseName: East & South Asia Database issn: 1672-6731 databaseCode: BVBZV dateStart: 20100101 customDbUrl: isFulltext: true dateEnd: 99991231 titleUrlDefault: https://search.proquest.com/eastsouthasia omitProxy: false ssIdentifier: ssj0001130260 providerName: ProQuest – providerCode: PRVPQU databaseName: ProQuest Central issn: 1672-6731 databaseCode: BENPR dateStart: 20100101 customDbUrl: http://www.proquest.com/pqcentral?accountid=15518 isFulltext: true dateEnd: 99991231 titleUrlDefault: https://www.proquest.com/central omitProxy: true ssIdentifier: ssj0001130260 providerName: ProQuest |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3Na9RAFB_6AcWL39JaLUU6pyU1yUwyM94yu1mK0CJSobdlJ5u09LBV24LsqQeVKoge1GLRgl7Egyhee_CvaVr_C9-bpLtRpKiX7OPNvDe_l5edeTOZNyFkxs94aEQqHTcL2g5XXuC0ecIdiHRDo5Rx_Q4mOM8vhHN3-M2lYGlo-Exl19LmhplNen_MK_kfrwIP_IpZsv_g2b5SYAAN_oUreBiuf-VjGodURlQJGksaebhrIQ6odqlsYpFqUN3EItmgERCCSkUjhUXap1ojR4WluAyo4jRWVIFCWwe0RQKJyLd1gGhYKRAJqJSWiKmqWz0RlXw-hVg0tmUyPC52q_EvjTnVEhVBNaWpblhYMYLGIk0jhpwoQFkggCObJVBtOQAFsBbmSd8a3KSqP5xaBjaLRgGh45q1SlnECkUUq1n5OtVeCUhbQJEEZs0KuhZjaE2RtRKktMZraEDY6oATVVmDlbQE1KtXV1KKlNGy2w-Fj0kQ3i_jgqg8_6zSyXsirMQLXvGJu9-HIqZCZYcibGC23wBuJhTFsbp8MAT3N0aGECp4TDI2TEZ9AbHTCBnV8cKt24MQFxM7ByE6TCiFcAdvgvH7AVwMQurAY6FU5RFrdt0R31QXyfPHmMbITAn4-klw8fSRlbXu8j2IqWyKWzdrd5cr0djiWXK6nEZNR8V_4hwZ6q2cJ2Pz5UaRC-RG_nTn6P3Wwdfn-bvvR8--HD75lH_bP3y9c_To5Y_dN_nWx_zDTv55P3-1ne-9Pdx9iI_uwfbjfO_FRbLYjBfrc075mRAngdjSSX03SBUzYLsxLEk6biZT4XX8LIHZL2srw0Tiwq_yeDvjiUkExuhtIVibKSPZJTLSXeum42Q6UzCepRnMeToJx3OZjEmz1ONGKpjVMDlBJvt3oHW3OA2m1XfZBLlW3pNW2Uestx501ldXTa-Ht9HFw-0un6hikpzCmsUS3xUysnF_M70KQe-GmSqfgym7aPQT8HCA0w |
| linkProvider | ProQuest |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=%E6%8A%97%E8%A1%80%E5%B0%8F%E6%9D%BF%E8%8D%AF%E7%89%A9%E6%B2%BB%E7%96%97%E8%85%94%E9%9A%99%E6%80%A7%E6%A2%97%E6%AD%BB%E6%95%88%E6%9E%9C%E7%9A%84Meta%E5%88%86%E6%9E%90&rft.jtitle=%E4%B8%AD%E5%9B%BD%E7%8E%B0%E4%BB%A3%E7%A5%9E%E7%BB%8F%E7%96%BE%E7%97%85%E6%9D%82%E5%BF%97&rft.au=%E5%BE%90%E8%BE%BE+%E9%99%88%E9%82%93+%E6%9C%B1%E4%B8%BD%E5%A8%9C+%E8%B0%AD%E6%88%88+%E7%8E%8B%E6%B5%B7%E5%A7%A3+%E5%88%98%E5%87%8C&rft.date=2017&rft.issn=1672-6731&rft.volume=17&rft.issue=3&rft.spage=176&rft.epage=184&rft_id=info:doi/10.3969%2Fj.issn.1672-6731.2017.03.004&rft.externalDocID=671813833 |
| thumbnail_s | http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=http%3A%2F%2Fimage.cqvip.com%2Fvip1000%2Fqk%2F84230A%2F84230A.jpg http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=http%3A%2F%2Fwww.wanfangdata.com.cn%2Fimages%2FPeriodicalImages%2Fxdsjjbzz%2Fxdsjjbzz.jpg |